Tempus Labs operates a healthcare data analytics platform that uses artificial intelligence to revolutionize the field of medicine. The company offers genomic sequencing services and utilizes its extensive library of clinical and molecular data through an operating system to analyze molecular and therapeutic data. This allows users to make data-driven decisions in real-time. Tempus Labs' innovative platform enables physicians to provide personalized care for their patients through interactive analytics and machine learning.
Baillie Gifford, Ares Management, Revolution Group, Novo Holdings, Lightbank, Kinship Trust Company, T. Rowe Price, Revolution (Washington DC), Alphabet, Kilmahew Ventures, Franklin Templeton, Franklin Venture Partners, Illinois Growth and Innovation Fund, Ares Capital Corporation BDC.